Net Loss of Bafna Pharmaceuticals reported to Rs 0.66 crore in the quarter ended March 2013 as against net loss of Rs 2.09 crore during the previous quarter ended March 2012. Sales rose 42.97% to Rs 46.81 crore in the quarter ended March 2013 as against Rs 32.74 crore during the previous quarter ended March 2012.
For the Audited full year,net profit rose 87.44% to Rs 3.88 crore in the year ended March 2013 as against Rs 2.07 crore during the previous year ended March 2012. Sales rose 34.84% to Rs 167.14 crore in the year ended March 2013 as against Rs 123.95 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales46.8132.74 43 167.14123.95 35 OPM %5.624.00 40 12.5514.85 -16 PBDT0.961.26 -24 12.7711.33 13 PBT-1.241.73 PL 5.185.49 -6 NP-0.66-2.09 68 3.882.07 87
Powered by Capital Market - Live News
